XBIOTECH INC's ticker is XBIT and the CUSIP is 98400H102. A total of 64 filers reported holding XBIOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,550 | -52.7% | 16,153 | -31.8% | 0.00% | – |
Q2 2023 | $140,772 | +30.9% | 23,699 | -24.0% | 0.00% | – |
Q1 2023 | $107,551 | +124.9% | 31,174 | +128.8% | 0.00% | – |
Q4 2022 | $47,824 | -89.5% | 13,625 | -83.2% | 0.00% | – |
Q2 2022 | $455,000 | +27.8% | 80,884 | +96.0% | 0.00% | – |
Q1 2022 | $356,000 | -54.4% | 41,269 | -31.5% | 0.00% | – |
Q3 2021 | $780,000 | -10.9% | 60,228 | +14.1% | 0.00% | – |
Q2 2021 | $875,000 | -15.5% | 52,800 | -12.4% | 0.00% | – |
Q1 2021 | $1,035,000 | -10.9% | 60,300 | -18.7% | 0.00% | – |
Q4 2020 | $1,161,000 | +79.4% | 74,200 | +119.1% | 0.00% | – |
Q3 2020 | $647,000 | +78.2% | 33,867 | -0.8% | 0.00% | – |
Q1 2020 | $363,000 | +148.6% | 34,134 | +77.5% | 0.00% | – |
Q2 2019 | $146,000 | +105.6% | 19,227 | +21.7% | 0.00% | – |
Q2 2018 | $71,000 | +20.3% | 15,800 | +43.6% | 0.00% | – |
Q1 2018 | $59,000 | -3.3% | 11,000 | -29.5% | 0.00% | – |
Q4 2017 | $61,000 | -43.5% | 15,600 | -36.6% | 0.00% | – |
Q3 2017 | $108,000 | -71.6% | 24,600 | -69.6% | 0.00% | – |
Q2 2017 | $380,000 | +43.9% | 80,961 | +406.0% | 0.00% | – |
Q1 2017 | $264,000 | – | 16,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ORACLE INVESTMENT MANAGEMENT INC | 500,000 | $674,000 | 0.10% |
LGT Fund Management Co Ltd. | 10,000 | $111,000 | 0.03% |
Trexquant Investment LP | 20,648 | $230,000 | 0.01% |
Thomasville National Bank | 13,350 | $149,000 | 0.01% |
CAXTON ASSOCIATES LP | 10,309 | $115,000 | 0.01% |
Ergoteles LLC | 14,200 | $158,000 | 0.01% |
High Net Worth Advisory Group LLC | 1,500 | $17,000 | 0.01% |
Financial Connections Group, Inc. | 500 | $5,000 | 0.01% |
ALPS ADVISORS INC | 35,176 | $392,000 | 0.00% |
HRT FINANCIAL LP | 43,825 | $487,000 | 0.00% |